The interaction of several biogenic amines and Compound A (2-(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride), an analogue of the active substance in a HPLC fraction isolated from the shrub, Salsola tuberculatiformis Botsch., with cytochrome P450c11 was investigated. Noradrenaline, octopamine and Compound A inhibited the type I DOC induced difference spectrum of P450c11 and elicited a type II difference spectrum when added alone. The Ks-values for noradrenaline, octopamine, and Compound A were 0.8 mM, 0.16 mM and 0.36 mM, respectively. Dopamine, adrenaline and synephrine did not interact with, or inhibit, P450c11. Further investigation of Compound A indicated that it is a mixed inhibitor of sheep P450c11 with a stronger competitive (Kic = 106-110 M) than uncompetitive (Kiu = 667-737 M) element.
INTRODUCTION
During an investigation of bioactive substances in the Namibian shrub, Salsola tuberculatiformis Botsch., high performance liquid chromatography (HPLC) analyses of an 11-hydroxylase (P450c11) inhibiting fraction yielded two potentially active fractions. Further analyses of these two fractions indicated the presence of an aziridine in the first, and dopamine in the second fraction [1] . The aziridine containing fraction, labeled S2, inhibited the binding of deoxycorticosterone to P450c11 [2] . The active substance(s) in this fraction were, however, extremely unstable and activity was lost during exposure to light, oxygen and high pH. The major breakdown product of S2 was synephrine, which did not inhibit P450c11. This suggested that S2 contained a P450c11 inhibiting aziridine, aziridine precursor or biogenic amine. The presence of dopamine in the second fraction was therefore interesting and although dopamine did not inhibit P450c11, the possibility that it was a breakdown product of a more active biogenic amine precursor in the plant could not be ruled out. Aziridines are found in nature as mitomycins and are highly reactive N-tricyclic compounds used in cancer treatment [3] . The reactivity of aziridines prompted the use of more stable precursors in clinical studies [4] . The presence of the breakdown product, synephrine, and data obtained from masspectrometry (MS) and nuclear magnetic resonance (NMR) studies prompted the syntheses of a more stable precursor, 2- 
MATERIALS AND METHODS

Substrate Induced Difference Spectra
Lyophilised mitochondrial powder from sheep adrenals was used as a source of cytochrome P450c11 and the spectral assays were performed as previously published [2, 5] . Compound A was prepared in PBS, immediately added to the test system, and spectra were recorded within 5 minutes; the biogenic amines were prepared in water. Two types of spectral assays were done: (1) substrate induced difference spectra by octopamine, noradrenaline, and Compound A and (2) inhibition of DOC-induced difference spectra by the same compounds. To 1 The two biogenic amines had no significant interaction with P450scc and it can be assumed that all the interactions between the amines and P450 could be attributed to P450c11 (unpublished). 
